Search This Blog

Wednesday, 28 June 2017

Experts at the EACPT Prague Congress discuss Global Health and Access to Safe Medicines

The EACPT 2017 Congress was held in Prague from 24th-27th June with 566 participants from all 5 continents - 28% from beyond the European Region, from Australia to China, Japan and South Korea to the USA. The Congress included 22 sessions with Keynote Lectures on current issues for research, education and clinical practice on safe and effective use of medicines.  
Access to Medicines (ensuring the supply chain for access to safe and effective medicines), is a high priority for health professionals, patients and health policy makers and funders within the European and global health perspective. The aim of the session at the EACPT Congress on this theme was to understand challenges and solutions for access to safe and effective medicines.

Panel speakers discuss highlights from the session in the video below.

Pavle Zelic, Jozef Glasa, Mike Isles and Donald Singer
1. To understand which organisations and individual categories of health professional are responsible for protecting patients from exposure to unsafe and ineffective medicines.
2. To understand potential weaknesses in the supply chain of medicines from production to dispensing.
3. To be aware of the risks to patients from accessing medicines from unreliable sources, including from unsafe internet 'pharmacies’ and unregulated “healers”.

Speakers and themes
1. Securing the supply chain of medicines: whose responsibility?
Mike Isles, Executive Director,
European Alliance for Access to Safe Medicines
2. Challenges and solutions for policy makers for access to medicines
Professor Jozef Glasa, Institute of Pharmacology, Clinical and Experimental Pharmacology and Institute of Health Care Ethics, Slovak Medical University in Bratislava 
3. Fight against falsified medicines: coordinated actions at EDQM level through the Medicrime Convention
Pavle Zelic, International Cooperation, European Integrations and Public Relations Manager, Medicines and Medical Devices Agency of Serbia

No comments:

Post a Comment